Published in Nursing Home and Elder Business Week, November 14th, 2004
The SurePath liquid-based Pap test is expected to be utilized in excess of 90% of the authority's total annual cervical cancer screening requirements. The SurePath test will be supplied by Medical Solutions plc, a cancer and pathology services group that serves as TriPath Imaging's licensed distributor in the United Kingdom.
TriPath Imaging, Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets and sells innovative solutions to improve the clinical management of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week